Skip to main content
Fig. 5 | BMC Cancer

Fig. 5

From: LAPTM4B is a novel diagnostic and prognostic marker for lung adenocarcinoma and associated with mutant EGFR

Fig. 5

Mutant promotes LAPTM4B expression related to PI3K/AKT signal in LAC cells. a Western blotting analysis of LAPTM4B protein expression after dose-dependent treatment with gefitinib in HCC827 and AZD9291 in H1975 cells. b Western blotting analyzed the expression levels of LAPTM4B in siRNAs-transfected HCC827 and H1975 cells. c Western blotting analysis of LAPTM4B protein levels after dose-dependent treatment with LY294002 in HCC827 and H1975 cells

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us